It’s only fair to share… Uplarafenib 1425485-87-5 494.5 g/mol Molecular Formula C22H21F3N4O4S Molecular Weight 494.487 UPLARAFENIB is a small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication. Neupharma, Inc. There are at least 400 enzymes identified as protein kinases. These enzymes catalyze the phosphorylation of target protein substrates. The …